妇科腹部手术后无阿片类处方出院的安全性与可行性
该回顾性队列研究纳入532例妇科肿瘤医生实施的腹部手术患者,通过术前宣教、围术期镇痛标准化及术后阿片处方算法进行质量改进。结果显示出院带阿片类处方比例从82.7%降至23.1%,人均处方片数从7.2片降至1.8片,而阿片续方或新开处方率及术后疼痛电话无显著变化。
要点
- 质量改进干预可大幅减少妇科腹部手术后阿片类出院处方。
核心结论
- 在适当教育和围术期镇痛实践下,择期妇科腹部手术患者可安全地无阿片类处方出院。
研究设计与样本
- 回顾性队列研究,纳入城市三级学术医疗中心由妇科肿瘤医生实施的择期微创和开腹腹部手术,共分析532例手术,比较质量改进前后队列。
主要发现
- 出院带阿片类处方比例从82.7%(229/276)降至23.1%(59/256),P<.001,且所有手术途径均显著降低。
- 所有患者平均阿片片数从7.2片(SD=5.7)降至1.8片(SD=4.3),P<.001。
- 干预前后阿片续方或新开处方率分别为6.5%(18/276)和5.9%(15/256),P=.75;术后疼痛电话分别为8.3%(23/276)和10.9%(33/256)。
关键数值与推荐
- 质量改进措施包括术前宣教、围术期镇痛标准化和术后阿片处方算法。
临床怎么用
- 妇科腹部手术后可依据标准化宣教和镇痛方案,对多数患者避免常规阿片类出院处方,而不增加续方或疼痛相关电话。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To implement a quality-improvement intervention aimed at reducing unnecessary opioid prescriptions for patients who are undergoing gynecologic surgery. METHODS: This was a retrospective cohort study that included data from the pre- and post-quality-improvement initiative cohorts. Patients at an urban, tertiary academic medical center who were undergoing scheduled minimally invasive surgery and open abdominal surgery by a gynecologic oncologist were included. Patients underwent preoperative counseling, standardization of perioperative analgesia, and a postoperative opioid prescribing algorithm. Descriptive statistics were calculated for demographic and perioperative characteristics, process measures, and outcome measures. RESULTS: A total of 532 abdominal surgeries were analyzed. The total percentage of patients discharged with an opioid prescription decreased from 82.7% (n=229/276) to 23.1% (n=59/256) (P<.001) and was significantly reduced for all routes of surgery. The mean number of opioid tablets prescribed for all patients was significantly reduced from 7.2 tablets (SD=5.7) to 1.8 tablets (SD=4.3) (P<.001). Eighty-three percent of patients (n=97/117) who underwent minimally invasive hysterectomy and were discharged on postoperative day 0 or day 1 were not provided an opioid prescription. Fifty-one percent of patients who underwent laparotomy were discharged without an opioid prescription. The percentage of patients who required an opioid refill or new prescription in the preintervention and postintervention cohorts remained constant (6.5%, n=18/276 vs 5.9%, n=15/256, P=.75), as did postoperative calls for pain (8.3%, n=23/276 vs 10.9%, n=33/256). CONCLUSION: Patients who are undergoing scheduled abdominal gynecologic surgery can be safely discharged without opioid prescriptions with appropriate education and perioperative analgesia prescribing practices. These protocols and prescribing practices profoundly limit opioid prescriptions, which is an important factor in combating the ongoing opioid crisis.
引用
- Margolis B, Andriani L, Baumann K, et al. Safety and Feasibility of Discharge Without an Opioid Prescription for Patients Undergoing Gynecologic Surgery. Obstet Gynecol. 2020. PMID: 33156191. doi:10.1097/AOG.0000000000004158
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。